Jim Flatt, PhD, is the CEO of DMC Biotechnologies, Inc., a leader in biomanufacturing of life’s essential chemicals. DMC’s proprietary Dynamic Metabolic Control technology enables the lowest possible cost of chemicals production, along with more rapid and lower cost strain and process development. Prior to DMC, Jim was the co-founder and CEO of Brightseed®, the bioactives company that illuminates nature to restore human health through the Forager AI platform that has garnered multiple national and international awards. Jim has led transformative scientific and technological breakthrough food and consumer health innovations, including the development of novel plant-based protein products to mainstream marketplace. In previous roles, led R&D at Martek Biosciences as the pioneer of sustainably produced DHA omega-3 fatty acid for infant brain, eye, and cardiovascular health. Later, Jim was CTO at the pioneering synthetic biology company Synthetic Genomics, leading to development of biological solutions for crop protection and advantaged methods for developing DNA-based vaccines. Jim is a chemical and biochemical engineer with a PhD from the University of Wisconsin and degrees from MIT and UC Berkeley.

‍